retatrutide clinical trial updates New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats: • Reta clinical trial data &

A diabetes medication that quickly rose to fame for its weight loss effects has experts exploring how it might help treat everything from heart disease to sleep apnea.Ozempic, Wegovy, and Zepbound, which belong to a group of drugs called GLP-1 receptor agonists, are showing promise in helping manage several long-term health problems.

Twenty-seven participants were randomised to liraglutide (n=13) or placebo (n=14)

GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring hormone that plays a major role in blood sugar regulation and appetite controland its now a key part of medically supervised...

on Global Trade Plaza B2B Marketplace

Stopping Zepbound temporarily raises important questions about weight regain, metabolic changes, and safe restart protocols

PlexusDx offers compounded GLP-1 options with genetic testing to support informed provider conversations.